|
|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 1 to 20 of 32
| Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | | article (author version) | Takahashi, Yuka; Kameda, Hiraku; Miya, Aika; Nomoto, Hiroshi; Cho, Kyu Yong; Nakamura, Akinobu; Nishimura, Hiroki; Kimura, Hirokazu; Suzuki, Masaru; Konno, Satoshi; Shimizu, Ai; Matsuno, Yoshihiro; Okamoto, Michinari; Motegi, Hiroaki; Iwata, Naoko; Fujisawa, Haruki; Suzuki, Atsushi; Sugimura, Yoshihisa; Miyoshi, Hideaki; Atsumi, Tatsuya | Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis | - | Pituitary | - | 6-Apr-2023 |
| article | Nomoto, Hiroshi; Takahashi, Akihiro; Nakamura, Akinobu; Kurihara, Hiroyoshi; Takeuchi, Jun; Nagai, So; Taneda, Shinji; Miya, Aika; Kameda, Hiraku; Cho, Kyu Yong; Miyoshi, Hideaki; Atsumi, Tatsuya | Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin : study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study) | - | Bmj open diabetes research and care | - | Nov-2022 |
| article | Nomoto, Hiroshi; Furusawa, Sho; Nakamura, Akinobu; Takeuchi, Jun; Nagai, So; Yokoyama, Hiroki; Sakuma, Ichiro; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Miya, Aika; Kameda, Hiraku; Cho, Kyu Yong; Atsumi, Tatsuya; Miyoshi, Hideaki | Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes : protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 st | - | BMJ Open | - | May-2022 |
| article (author version) | Chiba, Koki; Kameda, Hiraku; Miya, Aika; Nomoto, Hiroshi; Cho, Kyu Yong; Nakamura, Akinobu; Jin, Shigeki; Matoba, Kotaro; Miyoshi, Hideaki; Atsumi, Tatsuya | False Hypercortisolemia Due to Abnormal Albumin-Cortisol Binding in a Patient with Familial Dysalbuminemic Hyperthyroxinemia | - | Thyroid | - | 10-Feb-2022 |
| article | Kamoshima, Hikaru; Nomoto, Hiroshi; Yamashita, Kumiko; Takahashi, Yuka; Tsuchida, Kazuhisa; Kuwabara, Saki; Miya, Aika; Cho, Kyu Yong; Kameda, Hiraku; Nakamura, Akinobu; Atsumi, Tatsuya; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Ono, Yuri; Miyoshi, Hideaki | Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes? | - | Endocrine journal | - | 28-Jan-2022 |
| article | Miya, Aika; Nakamura, Akinobu; Cho, Kyu Yong; Kawata, Shinichiro; Nomoto, Hiroshi; Nagai, So; Sugawara, Hajime; Taneda, Shinji; Tsuchida, Kazuhisa; Omori, Kazuno; Yokoyama, Hiroki; Takeuchi, Jun; Aoki, Shin; Kurihara, Yoshio; Atsumi, Tatsuya; Miyoshi, Hideaki | Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients type 2 diabetes treated with canagliflozin plus teneligliptin | - | Journal of Diabetes Investigation | - | 10-Aug-2021 |
| article | Cho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Kawata, Shinichiro; Sugawara, Hajime; Takeuchi, Jun; Nagai, So; Omori, Kazuno; Tsuchida, Kazuhisa; Miya, Aika; Shigesawa, Ikumi; Tsuchida, Kenichi; Yanagiya, Shingo; Kameda, Hiraku; Yokoyama, Hiroki; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Nishimoto, Naoki; Atsumi, Tatsuya; Miyoshi, Hideaki | Improved Time in Range and Postprandial Hyperglycemia with Canagliflozin in Combination with Teneligliptin : Secondary Analyses of the CALMER study | - | Journal of Diabetes Investigation | - | 10-Aug-2021 |
| article | Cho, Kyu Yong; Nakamura, Akinobu; Omori, Kazuno; Takase, Takahiro; Miya, Aika; Yamamoto, Kohei; Nomoto, Hiroshi; Kameda, Hiraku; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone | - | Journal of Diabetes Investigation | - | 8-Jul-2021 |
| article | Miyoshi, Arina; Kameda, Hiraku; Nagai, So; Nakamura, Akinobu; Miya, Aika; Takase, Takahiro; Atsumi, Tatsuya; Miyoshi, Hideaki | Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis | - | Journal of Diabetes Investigation | - | 8-Jul-2021 |
| article | Miya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Miyoshi, Hideaki; Atsumi, Tatsuya | Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment | - | Journal of diabetes investigation | - | May-2021 |
| article | Miya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya | Log-linear relationship between endogenous insulin secretion and glycemic variability in patients with type 2 diabetes on continuous glucose monitoring | - | Scientific reports | - | 27-Apr-2021 |
| article | Handa, Takahisa; Nakamura, Akinobu; Miya, Aika; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Yoshioka, Narihito; Miyoshi, Hideaki; Atsumi, Tatsuya | The association between hypoglycemia and glycemic variability in elderly patients with type 2 diabetes: a prospective observational study | - | Diabetology and metabolic syndrome | - | 1-Apr-2021 |
| article | Chiba, Koki; Nomoto, Hiroshi; Nakamura, Akinobu; Cho, Kyu Yong; Yamashita, Kumiko; Shibayama, Yui; Miya, Aika; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Sodium–glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes | - | Journal of Diabetes Investigation | - | Feb-2021 |
| article | Chiba, Koki; Nomoto, Hiroshi; Nakamura, Akinobu; Cho, Kyu Yong; Yamashita, Kumiko; Shibayama, Yui; Miya, Aika; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Sodium-glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes | - | Journal of diabetes investigation | - | Feb-2021 |
| dataset | Miya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya | [Dataset] The coefficient of variation distribution among the three C-peptide subgroups  | - | - | - | 22-Dec-2020 |
| dataset | Miya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya | [Dataset] The calculated variance inflation factors | - | - | - | 22-Dec-2020 |
| dataset | Miya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya | [Dataset] Relationships between clinically relevant factors and log-transformed LBGI, according to multiple regression analysis | - | - | - | 22-Dec-2020 |
| dataset | Miya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya | [Dataset] The scatter plot for low blood glucose index | - | - | - | 22-Dec-2020 |
| dataset | Miya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya | [Dataset] The scatter plot for coefficient of variation | - | - | - | 22-Dec-2020 |
| dataset | Miya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya | [Dataset] Correlations in the items associated with coefficient of variation | - | - | - | 22-Dec-2020 |
Showing results 1 to 20 of 32
|
